Lundbeck
HLUN-B.CO
#2582
Rank
C$7.71 B
Marketcap
$8.10
Share price
-0.98%
Change (1 day)
28.32%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total debt

Total debt on the balance sheet as of September 2024 : C$0.90 Billion

According to Lundbeck 's latest financial reports the company's total debt is C$0.90 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Lundbeck - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31C$0.81 B-25.21%
2022-12-31C$1.09 B5.57%
2021-12-31C$1.03 B-37.9%
2020-12-31C$1.66 B-11.34%
2019-12-31C$1.87 B
2018-12-31N/A-100%
2017-12-31C$11.55 M-96.8%
2016-12-31C$0.36 B-52.93%
2015-12-31C$0.76 B20.95%
2014-12-31C$0.63 B48.84%
2013-12-31C$0.42 B26.47%
2012-12-31C$0.33 B-1.07%
2011-12-31C$0.34 B-1.18%
2010-12-31C$0.34 B-51.12%
2009-12-31C$0.70 B62.02%
2008-12-31C$0.43 B19.48%
2007-12-31C$0.36 B23%
2006-12-31C$0.29 B318.01%
2005-12-31C$70.76 M-21.12%
2004-12-31C$89.71 M